Skip to content

Comparison of the Functional Properties of Two Injectable Materials in Posterior Teeth: Randomized Clinical Trial

Comparison of the Functional Properties of Two Injectable Materials in Posterior Teeth: Randomized Clinical Trial

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06894186
Enrollment
52
Registered
2025-03-25
Start date
2025-03-31
Completion date
2026-04-30
Last updated
2025-03-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Class II Dental Caries, Dental Caries, Injectable Composite

Brief summary

Using two different injectable materials in class II cavities to compare functional properties

Interventions

OTHERGaenial universal injectable

GC Gaenial universal injectable advanced injectable composite with nano sized filler that merge the adaptation of flowable composite and mechanical properties of hybird composite

Sponsors

Future University in Egypt
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
21 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

* 1-Adult patients (20-50) 2-Good oral hygiene Good oral hygiene (Plaque index ≤2 (Moderate accumulation with plaque in the sulcus)) 3-Patient approval 4-Absence of parafunctional habits and/or bruxism 5-No endodontic treatment or abscess 6- class II either mesial or distal (no MOD cavities)

Exclusion criteria

* 1\. Systematic disease that may affect participation. 2. Xerostomic patients. 3. Bad oral hygiene (plaque index 2 or 3) 14 4. Heavy smokers 5. Patients undergoing or will start orthodontic treatment 6. Signs and symptoms of irreversible pulpitis.

Design outcomes

Primary

MeasureTime frame
Marginal adaptationT1: 1week T2: 6months T3 12 months
1- fracture of restoration and retention 2- proximal contact poiontT(Time) T1:1 week hours beasline T2: 6 months T3:12 months

Contacts

Primary ContactNourhan Elsayed Abdelrhman, BDS
Khalilnourhan1@gmail.com01111001709

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026